Pataday (Olopatadine)

This is a medication used as eye drops to treat itchy, red, and swollen eyes caused by allergies. It works by reducing inflammation and itching in the eye. It's a type of antihistamine.

Brand names:Patanol, Pataday, Patanase
Medication

What people taking Pataday (Olopatadine) report

Every report comes from a Lived member, sent anonymously.

Have you tried Pataday (Olopatadine) for Allergic Conjunctivitis?

NameHow it went

About Pataday (Olopatadine)

What It's For

Olopatadine is an antihistamine eye drop used to relieve the itching of allergic conjunctivitis, an allergic reaction in the thin membrane that covers the white of the eye and lines the eyelids. Common triggers include pollen, ragweed, grass, animal hair and dander. Patanol was the original prescription brand of the 0.1% drop. It is no longer sold in the US, and the same 0.1% product is now available without a prescription as Pataday Twice Daily Relief. Once-a-day versions are also sold over the counter: Pataday Once Daily Relief at 0.2%, and a stronger 0.7% drop that was previously sold as Pazeo. Store-brand generics exist at each strength. The 0.1% drop is labeled to relieve both itching and redness, while the once-daily strengths are labeled for itching. These drops are meant for eye allergy. Their labels say not to use them for irritation caused by contact lenses. Olopatadine also comes as a prescription nasal spray for hay fever symptoms in the nose; that is a separate product with its own instructions.

How It Works

In an allergic reaction, immune cells in the eye's surface called mast cells release histamine. Histamine attaches to a type of histamine receptor, known as H1, on nearby nerves and blood vessels, which produces the itch and widens small vessels so the eye looks red and watery. Olopatadine interrupts this in two ways. It blocks H1 receptors, so histamine that has already been released has less effect, and it reduces the amount of histamine mast cells release in the first place. It calms the reaction but does not change the underlying allergy, so symptoms can return when the drop wears off and the trigger is still around. Very little of the drug reaches the bloodstream when it is used in the eye.

Dosage & Administration

The schedule depends on the strength. The 0.1% drop (Pataday Twice Daily Relief, or the former Patanol) is one drop in each affected eye twice a day, 6 to 8 hours apart. The 0.2% and 0.7% drops are one drop in each affected eye once a day. Using more drops or more often than the label says does not add benefit. The nonprescription labels cover adults and children 2 years and older; for a child under 2, ask a doctor first. Wash your hands, tilt your head back, pull down the lower lid and let one drop fall into the pocket without the tip touching the eye or anything else. Closing the eye for a couple of minutes afterward helps the drop stay in place. If you use another eye product, wait at least 5 minutes between them. Do not use the solution if it has changed color or turned cloudy. Contact lens wearers should take lenses out before the drop and wait at least 10 minutes before putting them back in. The drops contain a preservative, benzalkonium chloride, that soft lenses can absorb. Do not wear lenses at all while the eye is red. If you miss a dose, use it when you remember unless the next one is nearly due, and do not double up.

Side Effects

Most people notice little beyond the drop itself. Brief burning or stinging, a short spell of blurred vision right after the drop, dry eyes, a feeling that something is in the eye, and mild redness are the effects most often reported. Headache was the most common complaint in the Patanol studies, affecting about 7 in 100 people, and a few people notice an odd taste. Some of these overlap with the allergy symptoms themselves. Stop using the drops and contact a doctor promptly if you develop eye pain or any change in your vision, since these are not part of ordinary eye allergy. Stop and check in with a doctor as well if the redness increases or the itching gets worse or lasts longer than 72 hours, which can mean the problem is not simple allergy or the drop is not the right fit.

Interactions & Warnings

Do not use olopatadine if you have had an allergic reaction to it or to any ingredient in the drop, including the preservative. Because so little of the drug enters the bloodstream, interactions with medicines taken by mouth are not a recognized concern on its labeling. It is still worth telling a pharmacist or doctor about other eye drops you use and other allergy treatments, and mentioning pregnancy or breastfeeding before starting. The drops are for use in the eye only.

What to Expect

Olopatadine works quickly. In studies where allergen was placed in the eye on purpose, the 0.1% drop protected against itching both right after a dose and when the challenge came up to 8 hours later. Reviews of clinical trials found that olopatadine and similar antihistamine eye drops reduce itching and redness better than a placebo drop, and it is generally well tolerated. Those trials lasted one to eight weeks, so there is little evidence about effects over many months of use. Many people use it through the season or the exposure that triggers their symptoms, and doing what you can to limit contact with the trigger still helps. If symptoms are not controlled, a clinician may suggest a different strength, another antihistamine eye drop such as alcaftadine, which relieved itching somewhat better than olopatadine in some head-to-head comparisons, or a check for a cause other than allergy.

Questions to Ask Your Doctor

  1. 1.Do my symptoms fit eye allergy, or could something else be causing the redness and itching?
  2. 2.Would a once-daily strength or the twice-daily 0.1% drop suit my symptoms better?
  3. 3.Should I use it every day during allergy season or only when symptoms flare?
  4. 4.How should I manage the drops around my contact lenses?
  5. 5.If the drops are not enough, what would we try next for my eyes or my other allergy symptoms?

Last reviewed • Oct 2026

Educational content, not medical advice.